Prevention of contact hypersensitivity to topically applied drugs by ethacrynic acid: potential application to transdermal drug delivery

[1]  J. Wille,et al.  Sensitization of mice to topically applied drugs: albuterol chlorpheniramine, clonidine and nadolol , 1996, Contact Dermatitis.

[2]  W. Jordan,et al.  Effect of coadministration of corticosteroids on the development of contact sensitization. , 1996, Journal of the American Academy of Dermatology.

[3]  R. Kalish,et al.  Sensitization of mice to paraphenylenediamine and structurally‐related compounds: adjuvant effects of vitamin A supplementation , 1995, Contact dermatitis.

[4]  R. Kalish.  Antigen processing: the gateway to the immune response. , 1995, Journal of the American Academy of Dermatology.

[5]  G. Senaldi,et al.  Protective effect of N-acetylcysteine in hapten-induced irritant and contact hypersensitivity reactions. , 1994, Journal of Investigative Dermatology.

[6]  C. Benezra,et al.  Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers * , 1994, Contact dermatitis.

[7]  Y. Aragane,et al.  Pentoxifylline suppresses irritant and contact hypersensitivity reactions. , 1993, The Journal of investigative dermatology.

[8]  P. Thorne,et al.  The noninvasive mouse ear swelling assay. I. Refinements for detecting weak contact sensitizers. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[9]  P. Thorne,et al.  The Noninvasive Mouse Ear Swelling Assay II. Testing the Contact Sensitizing Potency of Fragrances , 1991 .

[10]  S. Nummi,et al.  Transdermal oestrogen replacement therapy in a Finnish population. , 1991, Maturitas.

[11]  A. Bircher,et al.  Adverse skin reactions to nicotine in a transdermal therapeutic system , 1991, Contact dermatitis.

[12]  S. Zellner,et al.  Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension. , 1991, Clinical therapeutics.

[13]  M. Robinson,et al.  Evaluation of the Primary Skin Irritation and Allergic Contact Sensitization Potential of Transdermal Triprolidine , 1991 .

[14]  N. Dusitsin,et al.  Adverse skin reactions to transdermal oestradiol in tropical climate. A comparative study of skin tolerance after using oestradiol patch and gel in Thai postmenopausal women. , 1991, Maturitas.

[15]  P. Friedmann.  Pharmacological modulation of the skin immune system , 1990 .

[16]  W. Diezel,et al.  Inhibition of cutaneous contact hypersensitivity by calcium transport inhibitors lanthanum and diltiazem. , 1989, The Journal of investigative dermatology.

[17]  R. Gallo,et al.  Inhibition of allergic contact dermatitis and ultraviolet radiation-induced tissue swelling in the mouse by topical amiloride. , 1989, Archives of dermatology.

[18]  J. Shaw,et al.  Testing of controlled-release transdermal dosage forms. Product development and clinical trials. , 1987, Archives of dermatology.

[19]  H. Maibach.  Clonidine: irritant and allergic contact dermatitis assays , 1985, Contact dermatitis.

[20]  I. Andó,et al.  Genetic control of contact sensitivity to oxazolone in inbred, H‐2 congenic and intra‐H‐2 recombinant strains of mice , 1977, European journal of immunology.

[21]  R. Gallo,et al.  Structure-function relations in the inhibition of murine contact hypersensitivity by amiloride. , 1995, The Journal of investigative dermatology.

[22]  R. Kalish.  Recent developments in the pathogenesis of allergic contact dermatitis. , 1991, Archives of dermatology.